We've teamed up with Stand Up To Cancer and three partner organizations to fund $3.25 million in grants for treatment of FA-related head and neck cancer.
FA is associated with bone marrow failure, cancer predisposition, and congenital abnormalities. What do we know about central nervous system abnormalities?
Read updates about FA cancer research shared at the 2019 FARF Scientific Symposium
An update on three FA clinical trials presented at the 2019 FARF Scientific Symposium
Aldehydes can cause DNA damage to hematopoietic stem cells, leading to bone marrow failure and cancer. Where are we with research into aldehydes in FA? Read this update from the 2019 Symposium.
At the 2019 FARF Scientific Symposium in Chicago, Dr. Grant Rowe became the fourth recipient of the David B. Frohnmayer Early Investigator Award.
Investigators share updates from their current research on the FA pathway and revealed advancements that are reshaping our understanding of the functions of FA genes.